Compare IDXX & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | AU |
|---|---|---|
| Founded | 1983 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4B | 49.5B |
| IPO Year | 1996 | 2023 |
| Metric | IDXX | AU |
|---|---|---|
| Price | $518.33 | $98.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $721.67 | $119.00 |
| AVG Volume (30 Days) | 426.9K | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | ★ 22.59 | N/A |
| EPS | ★ 7.74 | N/A |
| Revenue | ★ $4,303,702,000.00 | N/A |
| Revenue This Year | $10.88 | $38.71 |
| Revenue Next Year | $8.59 | $2.89 |
| P/E Ratio | $66.33 | ★ $23.93 |
| Revenue Growth | ★ 10.42 | N/A |
| 52 Week Low | $500.61 | $62.55 |
| 52 Week High | $769.98 | $129.14 |
| Indicator | IDXX | AU |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 43.36 |
| Support Level | $500.61 | $89.75 |
| Resistance Level | $581.28 | $113.70 |
| Average True Range (ATR) | 11.20 | 2.72 |
| MACD | 1.64 | -1.36 |
| Stochastic Oscillator | 62.91 | 15.96 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Anglogold Ashanti PLC is an independent gold mining company. It has a diversified asset portfolio, including production from operations in eight countries (Argentina, Australia, Brazil, Egypt, Ghana, Guinea, the DRC, and Tanzania), supported by greenfield projects in the United States and Colombia. The company's main product is gold, which once mined, is processed into dore (unrefined gold bars) on site and then dispatched to precious metals refineries. Geographically, Anglogold generates maximum revenue from its operations in Africa (comprising operations at Kibali, Iduapriem, Obuasi, Siguiri, Geita, and Sukari mines), followed by Australia (including Sunrise Dam and Tropicana), and the Americas (comprising Cerro Vanguardia, AngloGold Ashanti Mineracao, and Serra Grande operations).